Veteran Manager Shifting Focus from Tech to Healthcare ETFs
· wellness
A Shift in Tides: The Market’s Move Beyond Tech
The S&P 500 has recently shown a stark contrast between technology and AI stocks, which have led the charge, and other sectors. Chris Versace, a veteran portfolio manager at TheStreet Pro Portfolio, is taking a contrarian approach by allocating his portfolio to new areas that he believes will drive growth over multiple years.
Versace’s key driver for this decision is the potential for growth in the healthcare sector. As the US population ages, demand for healthcare services will increase significantly. This reality is not new, but the market’s recent underperformance compared to tech stocks makes it an attractive entry point. The addition of Health Care Select Sector SPDR ETF (XLV) to his portfolio gives Versace broad exposure to pharmaceuticals, biotechnology, medical devices, and life sciences.
The robotics and automation thesis behind Robo Global Robotics and Automation Index ETF (ROBO) is equally compelling. Labor shortages and pressure to cut costs are plaguing various industries, prompting companies to turn to automation as a solution. This trend extends beyond manufacturing to logistics, healthcare, and agriculture. The depreciation provisions in the tax legislation will also provide a near-term boost to companies investing in automation and equipment.
Versace’s emphasis on building positions gradually over time is notable. He has done this before with First Trust Nasdaq Cybersecurity ETF (CIBR), using pullbacks as opportunities to add shares rather than buying everything at once. This strategy allows him to monitor how things develop without putting too much of his portfolio’s eggs in one basket.
The implications of Versace’s moves extend beyond these two positions. His decision to allocate 1% of his portfolio to XLV and 0.75% to ROBO suggests a cautious approach, given the market’s recent strength. This is a departure from some other managers who are still fully invested in tech stocks.
During earnings season, Wall Street analysts will update their numbers on the underlying holdings, prompting Versace to revisit his price targets for both ETFs. A strong quarter from Eli Lilly or AbbVie could push the XLV target higher, while better capital spending data or more clarity on automation policy would boost ROBO.
The real question is whether this shift in focus will be a bellwether for other managers to follow. If the healthcare and robotics/automation sectors continue to grow as Versace expects, it could signal a broader trend away from tech stocks and towards areas with more tangible demand drivers. Conversely, if these positions underperform, it may suggest that the market’s recent strength has been unsustainable.
The move beyond tech stocks will require close attention from investors who have grown accustomed to their dominance. As Versace said, “These are not trading positions; they’re intended to be held over a longer time horizon and built upon as opportunities arise.” The question now is whether others will follow his lead and begin to diversify their portfolios in response to changing market conditions.
The stakes are high for those who have bet heavily on tech stocks. A significant shift away from these sectors could leave many investors feeling left behind, struggling to adjust to a new landscape where the growth drivers of tomorrow may not be what they were yesterday. The next few months will tell if Versace’s contrarian approach is prescient or misguided – and whether it signals a broader change in the market’s trajectory.
Reader Views
- ANAlex N. · habit coach
While Chris Versace's decision to allocate 1% of his portfolio to Health Care Select Sector SPDR ETF (XLV) and Robo Global Robotics and Automation Index ETF (ROBO) is a savvy move, investors shouldn't get too carried away with the "buy low" mentality. The US healthcare industry faces significant regulatory hurdles, from reimbursement reforms to ongoing patent disputes in the pharmaceutical sector. Meanwhile, automation trends, although compelling, may stall as companies begin to reap diminishing returns on their investments. Prudent investors will want to exercise caution and monitor these sectors closely before committing a significant portion of their portfolio.
- DMDr. Maya O. · behavioral researcher
The shift in focus from tech to healthcare ETFs is a savvy move by Chris Versace, but investors should be cautious about the sector's correlation with interest rates. As rates rise, healthcare companies may see their profitability squeezed due to increased borrowing costs and reduced investor appetite for high-growth stocks. To mitigate this risk, Versace might consider diversifying his portfolio further or hedging against potential rate increases – a prudent approach in today's uncertain market landscape.
- TCThe Calm Desk · editorial
While Chris Versace's emphasis on healthcare and automation is warranted by demographic trends and industry pressure, investors should be cautious of the concentration risk in these sectors. The surge in ETFs tied to pharmaceuticals and robotics may not necessarily translate into outperformance if broader market conditions shift or regulatory changes impact these industries. A more diversified approach might serve investors better, spreading bets across multiple sectors to mitigate potential losses.